| scholarly article | Q13442814 |
| P50 | author | Stephen M. Husbands | Q42352975 |
| Jakub Fichna | Q22115026 | ||
| P2093 | author name string | Marta Zielińska | |
| Agata Jarmuż | |||
| Gerta Cami-Kobeci | |||
| Andrzej Wasilewski | |||
| P2860 | cites work | Antinociceptive, antidiarrheal, and neuropharmacological activities of Barringtonia acutangula | Q43347150 |
| Antisecretory effect of loperamide in colon epithelial cells by inhibition of basolateral K+ conductance | Q43667459 | ||
| Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating kappa-opioid and cannabinoid receptors | Q44343638 | ||
| Endomorphin analogues with mixed μ-opioid (MOP) receptor agonism/δ-opioid (DOP) receptor antagonism and lacking β-arrestin2 recruitment activity | Q44343837 | ||
| TH-030418: a potent long-acting opioid analgesic with low dependence liability | Q44350826 | ||
| Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity | Q44351610 | ||
| Mixed MOP/DOP agonist biphalin elicits anti-transit effect in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms | Q57105487 | ||
| Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome | Q57108024 | ||
| Gastrointestinal actions of buprenorphine: are different receptors involved? | Q71943056 | ||
| Regulation of intestinal Cl- and HCO3-secretion by uroguanylin | Q74518335 | ||
| Anti-inflammatory and antinociceptive action of the dimeric enkephalin peptide biphalin in the mouse model of colitis: new potential treatment of abdominal pain associated with inflammatory bowel diseases | Q87645850 | ||
| Dissociation of castor oil-induced diarrhoea and intestinal mucosal injury in rat: effect of NG-nitro-L-arginine methyl ester | Q28368875 | ||
| Functional bowel disorders | Q29620328 | ||
| Novel analgesics and molecular rearrangements in the morphine-thebaine group. III. Alcohols of the 6,14-endo-ethenotetrahydrooripavine series and derived analogs of N-allylnormorphine and -norcodeine | Q34054548 | ||
| The orvinols and related opioids--high affinity ligands with diverse efficacy profiles | Q34307193 | ||
| Opioid receptors in the gastrointestinal tract | Q35185222 | ||
| The regulation of veratridine-stimulated electrogenic ion transport in mouse colon by neuropeptide Y (NPY), Y1 and Y2 receptors | Q35545073 | ||
| Effects of mu and kappa opioid receptor agonists and antagonists on contraction of isolated colon strips of rats with cathartic colon | Q36067542 | ||
| Modulation of gastrointestinal function by MuDelta, a mixed µ opioid receptor agonist/ µ opioid receptor antagonist | Q36382976 | ||
| Effect of thienorphine on intestinal transit and isolated guinea-pig ileum contraction | Q36699289 | ||
| Orvinols with mixed kappa/mu opioid receptor agonist activity | Q36822435 | ||
| Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives | Q37491434 | ||
| Antidiarrheal activity of ethanolic extract of Manihot esculenta Crantz leaves in Wistar rats | Q39605053 | ||
| Insights into opioid action in the intestinal tract | Q41293298 | ||
| P433 | issue | 2 | |
| P921 | main subject | diarrhea | Q40878 |
| P304 | page(s) | 350-357 | |
| P577 | publication date | 2016-12-05 | |
| P1433 | published in | Pharmacological Reports | Q15766499 |
| P1476 | title | Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome | |
| P478 | volume | 69 |
| Q89459062 | Desensitization of transient receptor potential vanilloid type-1 (TRPV1) channel as promising therapy of irritable bowel syndrome: characterization of the action of palvanil in the mouse gastrointestinal tract |
| Q49677641 | Existing and emerging therapies for managing constipation and diarrhea |
Search more.